We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cynapsus Therapeutics Inc. (MM) | NASDAQ:CYNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 40.4805 | 20.12 | 40.54 | 0 | 01:00:00 |
Company to Host Conference Call Today at 2 p.m. PT/5 p.m. ET
Cyngn (or the “Company”) (NASDAQ: CYN), a developer of innovative autonomous driving software solutions for industrial and commercial enterprises, today announced its unaudited financial results for the third quarter ended September 30, 2021.
Background on Cyngn – A Company Targeting Full-scale Commercialization and Recurring Revenue Streams
Cyngn is a pre-revenue company developing the Enterprise Autonomy Suite (“EAS”) that combines advanced in-vehicle autonomous driving technology with leading supporting technologies like data analytics, fleet management, cloud, and connectivity. EAS provides a differentiated solution that the Company believes will drive pervasive proliferation of industrial autonomous vehicles and create value for customers at every stage of their journey towards full automation and the adoption of Industry 4.0.
EAS is currently available as a beta release, and both the components and the combined solution are still under development. Components of EAS have previously been used for a paid customer trial and pilot deployments; EAS is currently available to select beta customers. The Company expects EAS to continually be developed and enhanced according to evolving customer needs, which will take place concurrently while other completed features of EAS are commercialized.
Cyngn expects annual research and development (“R&D”) expenditures in the foreseeable future to equal or exceed that of 2019 and 2020. The Company also expects that limited paid pilot deployments in 2022 and 2023 will offset some of the ongoing R&D costs of continually developing EAS. The Company is targeting for scaled deployments to begin in 2024.
Recent Operating Highlights:
Management Commentary:
Lior Tal, Chairman and CEO of Cyngn, stated, “The last three months have been a landmark period in Cyngn’s journey, with the demand for industrial autonomous driving solutions serving as a catalyst for the development of our EAS. Subsequent to the quarter ended September 30, 2021, we were pleased to have successfully completed our IPO with the proceeds being immediately deployed into our daily operations and research and development of EAS. In addition to adding resources to our R&D team, our goal in the coming months will be to further develop our eco-system of partnerships like the one we announced with Columbia Vehicle Group last month and to deploy DriveMod, our end-to-end in-vehicle solution, on the various industrial vehicles of our OEM partners. These partnerships and subsequent beta deployments are key milestones as we work to productize our autonomous vehicle technologies toward full-scale commercialization of EAS.”
GAAP Financial Review for the Third Quarter Ended September 30, 2021:
Balance Sheet Highlights:
As of September 30, 2021, Cyngn’s cash and cash equivalents including restricted cash were $1.7 million, working capital was $1.5 million, and total stockholders’ equity was $0.03 million; compared to cash and cash equivalents of $6.5 million, working capital of $6.1 million and total stockholders’ equity of $5.6 million, respectively, as of December 31, 2020.
Including the proceeds from the IPO in October 2021, pro forma cash and cash equivalents including restricted cash, working capital and total stockholders’ equity as of September 30, 2021, are $25.0 million, $24.8 million and $23.3 million, respectively.
For more details on Cyngn’s financial results for the quarter ended September 30, 2021, please refer to the Company’s Quarterly Report on Form 10-Q to be filed with the SEC, which is accessible at www.sec.gov.
Conference Call and Webcast Information:
Cyngn will host a conference call at 2 p.m. PT/5 p.m. ET today (Wednesday, November 17, 2021), during which management will discuss the results of the third quarter ended September 30, 2021. To participate in the conference call, please use the following dial-in numbers about 5 minutes prior to the scheduled conference call time:
U.S. & Canada (Toll-Free): +1 (877) 407-9753
International (Toll): +1 (201) 493-6739
The conference call can also be accessed via webcast at: https://78449.themediaframe.com/dataconf/productusers/cyn/mediaframe/47383/indexl.html.
Those who are unable to attend the live conference call may access the recording shortly after the conclusion of the call at the above webcast link or at the “Investor Relations” page of the Company’s website (https://investors.cyngn.com/).
About Cyngn
Cyngn is an autonomous vehicle technology company that is focused on addressing industrial uses for autonomous vehicles. Cyngn believes that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbents, and high upfront investment requirements. Cyngn addresses these challenges with its Enterprise Autonomy Suite, which includes DriveMod (modular industrial vehicle autonomous driving software), Cyngn Insight (customer-facing software suite for monitoring/managing AV fleets and aggregating/analyzing data), and Cyngn Evolve (internal toolkit that enables Cyngn to leverage data from the field for artificial intelligence, simulation, and modeling).
To learn more, please visit www.cyngn.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements about the Company’s growth, acquisition strategy, ability to deliver sustainable long-term value, ability to respond to the changing environment, operational focus, strategic growth plans and merger integration efforts, operations and financial results. Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company’s management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company’s reports to the SEC, including, without limitation the risk factors discussed in the Company’s Prospectus. The forward-looking statements are applicable only as of the date on which they are made, and the Company does not assume any obligation to update any forward-looking statements.
CYNGN INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS September 30, December 31,2021
2020
(Unaudited) Assets Current assets Cash and cash equivalents$ 1,650,684
$ 6,056,190
Restricted cash50,000
400,000
Prepaid expenses and other current assets317,783
48,852
Total current assets2,018,467
6,505,042
Property and equipment, net70,197
133,805
Intangible assets, net31,783
34,383
Total Assets$ 2,120,447
$ 6,673,230
Liabilities and Stockholders' Equity Current liabilities Accounts payable269,231
73,016
Accrued expenses and other current liabilities218,588
307,402
Total current liabilities487,819
380,418
Note payable, Payroll Protection Program1,602,936
695,078
Total liabilities2,090,755
1,075,496
Stockholders' Equity Convertible preferred stock, Par $0.00001; 21,982,491shares authorized, issued and outstanding as of December31, 2020 and 2019, respectively220
220
Common stock, Par $0.00001; 42,000,000 sharesauthorized, 966,210 and 951,794 shares issued andoutstanding as of September 30, 2021 and December 31,2020, respectively10
10
Additional paid-in capital114,466,043
114,291,505
Accumulated deficit(114,436,581)
(108,694,001)
Total stockholders' equity29,692
5,597,734
Total Liabilities and Stockholders' Equity$ 2,120,447
$ 6,673,230
CYNGN INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Three months ended September 30, Nine months ended September 30,
2021
2020
2021
2020
Revenue$
-
$
-
$
-
Operating expenses: Research and development
1,151,109
1,496,883
2,917,295
4,175,302
General and administrative
973,943
267,343
2,851,061
1,947,481
Total operating expenses
2,125,052
1,764,226
5,768,356
6,122,782
Loss from operations
(2,125,052)
(1,764,226)
(5,768,356)
(6,122,782)
Other income, net Interest (expense) income
(3,989)
1,604
(10,032)
35,580
Other income
29,856
450
35,808
11,119
Total other income, net
25,867
2,054
25,776
46,699
Net loss$
(2,099,185)
$
(1,762,172)
$
(5,742,580)
$
(6,076,084)
Net loss per share attributable toordinary shareholders, basic anddiluted$
(2.17)
$
(1.85)
$
(5.94)
$
(6.38)
Weighted-average shares used incomputing net loss per shareattributable to ordinary shareholders,basic and diluted
966,210
951,794
966,210
951,794
CYNGN INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Nine months ended September 30,
2021
2020
Cash flows from operating activities Net loss$
(5,742,580)
$
(6,076,084)
Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization
68,597
68,727
Stock-based compensation
166,458
130,521
Gain in disposal of assets
(31,356)
-
Changes in operating assets and liabilities: Prepaid expenses and other current assets
(268,931)
33,440
Accounts payable and accrued expenses
196,215
(108,944)
Other current liabilities
(88,812)
13,985
Net cash used in operating activities
(5,700,409)
(5,938,354)
Cash flows from investing activities Purchase of property, plant, and equipment
(18,224)
-
Disposal of assets
47,189
-
Net cash used in investing activities
28,965
-
Cash flows from financing activities Proceeds from note payable, inclusive of accrued interest
907,858
698,322
Proceeds from exercise of stock options
8,080
623
Net cash provided by financing activities
915,938
698,945
Net decrease in cash and cash equivalents and restricted cash
(4,755,506)
(5,239,409)
Cash and cash equivalents and restricted cash, beginning of period
6,456,190
13,680,550
Cash and cash equivalents and restricted cash, end of period$
1,700,684
$
8,441,141
Supplemental disclosure of cash flow: Cash paid during the period for interest and taxes$
-
$
-
View source version on businesswire.com: https://www.businesswire.com/news/home/20211117006250/en/
Carolyne Sohn Vice President, The Equity Group csohn@equityny.com (415) 568-2255
1 Year Cynapsus Therapeutics Inc. Chart |
1 Month Cynapsus Therapeutics Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions